How Has The Cyberknife Market Size Evolved In Recent Years?
The cyberknife market has seen considerable growth due to a variety of factors.
•Over the past few years, the cyberknife market has seen a significant expansion. The market value is projected to increase from $0.63 billion in 2024 to $0.73 billion in 2025, a compound annual growth rate (CAGR) of 16.6%.
The historical growth can be linked to factors such as increasing instances of cancer, a growing older population, the need for precision in medical treatments, patient preference for non-surgical procedures, and technological advancements in radiotherapy.
What Are The Estimated Market Size And Expected Annual Growth Rates For Global Cyberknife Market?
The cyberknife market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, a notable surge is anticipated in the cyberknife market, which is forecast to reach a size of "$1.35 billion by 2029, climbing at a compounded annual growth rate (CAGR) of 16.6%.
The hike in growth during this forecast period can be tied to a rising global cancer burden, advancements in research related to oncology, an increase in healthcare accessibility, heightened awareness and education, and the combination of multidisciplinary strategies. Factors to watch during the forecast period include an increase in the integration of proton therapy, a trend towards outpatient and detached centers, treatments that prioritize patients, an upswing in clinical evidence and research, as well as a growing interest in telemedicine and remote treatment planning.
What Are The Essential Drivers Behind The Growth Of The Cyberknife Market?
The surge in cancer cases is predicted to boost the expansion of the cyberknife market. Cancer, a severe disease characterized by an uncontrolled and rapid multiplication of the body's cells leading to abnormal growth, can be treated by Cyberknife, a non-invasive, non-surgical, painless method used when radiation therapy is required. Continued research and development towards enhancing the Cyberknife system and broadening its use to other medical conditions is also anticipated to foster the market's growth. In January 2022, ABC News Internet Ventures, a US-based media firm, forecasted around 2 million new cancer cases in 2022, a substantial rise from the 1 million reported in 2021. Each day in the US, nearly 5,250 fresh cases of cancer are identified, which equates to 1,918,030 Americans diagnosed with the disease. As such, the escalating rate of cancer is fueling the expansion of the cyberknife market.
How Is The Global Cyberknife Market Divided Into Key Segments?
The cyberknife market covered in this report is segmented –
1) By Type: Linear Accelerator-Based, Standalone Cyberknife
2) By Application: Tumor, Cancer, Vascular malformation, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Center, Radiotherapy Centers, Other End Users
Subsegments:
1) By Linear Accelerator-Based: Conventional Linear Accelerators, Advanced Linear Accelerators, Integrated Linear Accelerators
2) By Standalone Cyberknife: Fixed Cyberknife Systems, Mobile Cyberknife Systems, Upgraded Cyberknife Systems
Pre-Book The Cyberknife Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Cyberknife Market?
Key operators in the cyberknife market are honing in on developing innovative solutions like medical training initiatives in an effort to increase the accuracy of treatments, better patient outcomes, and broaden the spectrum of conditions that can be treated, all while lessening the side effects typically tied to conventional radiation therapies. Medical training initiatives are structured education programs created to boost the competencies and understanding of health professionals, with emphasis on specific medical technologies, procedures, and optimal methods to enhance the outcomes for patient care. For example, in September 2024, Accuray Incorporated, an American company specializing in radiation therapy systems manufacturing, launched the CyberKnife S7 System medical professional training at their educational hub. This facility functions as an all-inclusive education hub with the aim to boost the expertise of medical personnel engaged in radiosurgery and radiotherapy, providing customized training programs and hands-on exposure to the CyberKnife and Radixact systems.
Who Are the Key Players in the Cyberknife Market?
Major companies operating in the cyberknife market include:
• Accuray Incorporated
• Elekta AB
• Medtronic plc
• Varian Medical Systems Inc.
• Brainlab AG
• Ion Beam Applications S.A.
• Mevion Medical Systems Inc.
• Zap Surgical Systems Inc.
• Xcision Medical Systems LLC
• ViewRay Inc.
• Hitachi Ltd.
• Mitsubishi Electric Corporation
• Best Theratronics Ltd.
• Siemens Healthineers AG
• Toshiba Medical Systems Corporation
• Orfit Industries NV
• Technicare Medical Systems Inc.
• ProTom International Inc.
• Advanced Accelerator Applications S.A.
• Theragenics Corporation
• IntraOp Medical Corporation
• CIVCO Radiotherapy
• IsoRay Medical Inc.
• RaySearch Laboratories AB
• RefleXion Medical Inc.
• Shinva Medical Instrument Co. Ltd.
• Klarity Medical Products
• MIM Software Inc.
• Elekta Instrument AB
• Nordion Inc.
What are the Regional Insights into the Cyberknife Market?
North America was the largest region in the cyberknife market in 2024. The regions covered in the cyberknife market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
